By Counterforce Health Team in Soliris (eculizumab) —

Renewing Soliris (Eculizumab) Approval with Blue Cross Blue Shield in Florida: Complete 2025 Guide with Forms and Timelines

Answer Box: Renewing Soliris Coverage in Florida

Florida Blue Cross Blue Shield requires annual Soliris (eculizumab) renewal with updated clinical documentation 30-60 days before expiration. Key requirements include: current lab results showing disease response, up-to-date meningococcal vaccination records, REMS compliance documentation, and step therapy completion records. Submit via Availity.com provider portal or contact medical pharmacy team. If denied, you have 180 days to file internal appeals and 4 months for external review through Florida Department of Financial Services.

First step today: Check your current authorization expiration date on your EOB or by calling the member services number on your insurance card.

Table of Contents

  1. When to Start Your Renewal Process
  2. Required Documentation for 2025
  3. Building Your Renewal Packet
  4. Submission Timeline and Decision Windows
  5. If Your Coverage Lapses
  6. Annual Plan Changes to Watch
  7. Appeals Process for Denied Renewals
  8. Personal Renewal Tracker
  9. FAQ

Renewal Triggers: When to Start Early

Most Florida Blue Cross Blue Shield Soliris authorizations are approved for 12-month periods. However, you shouldn't wait until the last minute to begin your renewal process.

Start Your Renewal 60-90 Days Early If:

  • Your current authorization expires between October-January (high-volume renewal period)
  • You've had any changes in your clinical condition or treatment response
  • New step therapy requirements have been implemented (effective July 2024 for many Florida Blue plans)
  • You're switching between Florida Blue plans during open enrollment

Red Flags That Require Immediate Action:

  • Formulary changes: Florida Blue may move Soliris to a higher tier or add restrictions during annual plan updates
  • Biosimilar preferences: As of late 2025, some Florida Blue plans prefer Bkemv™ (eculizumab-aeeb) over Soliris
  • REMS compliance issues: Any gaps in meningococcal vaccination or prescriber enrollment
Tip: Set a calendar reminder 90 days before your authorization expires. This gives you time to gather documentation and address any issues before your current coverage runs out.

Required Documentation for 2025

Florida Blue's 2025 renewal requirements have become more stringent, particularly around safety monitoring and step therapy compliance.

Core Clinical Documentation

Disease Response Evidence:

  • Updated lab results within the last 3 months showing:
    • For PNH: LDH levels, hemoglobin, platelet count, transfusion requirements
    • For aHUS: Serum creatinine/eGFR, LDH, platelet count, plasma exchange needs
    • For gMG/NMOSD: Clinical assessment scores (MG-ADL for gMG), CH50 levels

Safety Monitoring Records:

New 2025 Requirements

Step Therapy Documentation: Since July 2024, Florida Blue requires proof of:

Site of Care Justification:

  • Specify preferred infusion location (home, office, infusion center)
  • Additional justification required for hospital-based administration

Building Your Renewal Packet

Medical Necessity Letter Update Structure

Your prescriber's renewal letter should address:

  1. Current clinical status and response to Soliris therapy
  2. Laboratory evidence of continued benefit
  3. Safety profile - absence of unacceptable toxicity
  4. Step therapy compliance or exemption rationale
  5. Continued medical necessity with guideline references

Essential Supporting Documents

Document Type What to Include Where to Obtain
Lab Results LDH, hemoglobin, creatinine, platelets (last 3 months) Treating physician
Vaccination Records MenACWY and MenB dates and documentation Provider's office or state immunization registry
Clinical Notes Recent visit notes documenting response and tolerability Medical records department
Prior Authorization History Previous approvals and any denials Florida Blue member portal

Submission Timeline and Decision Windows

Optimal Submission Schedule

90 days before expiration:

  • Begin gathering documentation
  • Schedule lab work if needed
  • Verify REMS compliance

60 days before expiration:

  • Submit complete renewal packet
  • Follow up within 5 business days to confirm receipt

30 days before expiration:

  • If no decision received, submit expedited request
  • Prepare appeal documentation as backup

Florida Blue Decision Timelines

  • Standard renewal: 15-30 business days
  • Expedited review: 72 hours (for urgent medical situations)
  • Peer-to-peer review: Additional 5-10 business days if requested

Submit renewals through the Availity.com provider portal or contact Florida Blue's medical pharmacy team directly.

If Your Coverage Lapses

Immediate Bridge Options

Emergency Supply:

  • Most specialty pharmacies can provide a 7-14 day emergency supply
  • Contact your specialty pharmacy immediately upon denial
  • May require partial payment pending appeal resolution

Urgent Appeal Process: If interrupting Soliris could cause serious harm:

  1. Have your prescriber submit an expedited appeal within 24 hours
  2. Emphasize medical urgency and risk of treatment interruption
  3. Request continuation of coverage during appeal review
From our advocates: "We've seen patients successfully obtain bridge coverage by having their specialist call Florida Blue directly and request an urgent peer-to-peer review. The key is emphasizing the immediate medical risk of missing even one infusion cycle."

Manufacturer Support Options

  • Alexion Access Navigator: Patient assistance programs and bridge therapy options
  • Copay assistance: May help with out-of-pocket costs during coverage gaps
  • Contact: Alexion Access Navigator program

Annual Plan Changes to Watch

2025-2026 Formulary Updates

Biosimilar Preferences:

  • Some Florida Blue plans now prefer Bkemv™ over brand Soliris
  • Epysqli may become preferred by early 2026
  • Action needed: Request formulary exception if switching isn't clinically appropriate

Step Therapy Expansions:

  • More plans requiring Empaveli® trial before Soliris approval
  • Stricter documentation requirements for medical exceptions

Plan Design Changes During Open Enrollment

Review these elements in your 2026 plan documents:

  • Specialty tier copays - may increase significantly
  • Prior authorization requirements - new restrictions may apply
  • Site of care limitations - preferred infusion locations may change
  • Quantity limits - dosing restrictions may be implemented

Appeals Process for Denied Renewals

Florida Blue Internal Appeals

Level 1 - Standard Appeal:

Level 2 - Peer-to-Peer Review:

  • Request within 30 days of Level 1 denial
  • Allows your specialist to speak directly with Florida Blue's medical director
  • Often more successful for complex specialty drug cases

Florida External Review Process

If internal appeals fail:

  • Deadline: 4 months (120 days) after final internal denial
  • Timeline: 45 days for standard decision, 72 hours for expedited
  • Cost: Free to consumers
  • Contact: Florida Department of Financial Services at 1-877-693-5236
  • Outcome: Binding decision - Florida Blue must comply if overturned

Personal Renewal Tracker

Renewal Checklist

90 Days Before Expiration:

  • Current authorization expiration date: ___________
  • Lab work scheduled: ___________
  • Vaccination status verified: ___________
  • REMS compliance confirmed: ___________

60 Days Before Expiration:

  • Medical necessity letter requested: ___________
  • Supporting documentation gathered: ___________
  • Renewal submitted via Availity: ___________
  • Confirmation number received: ___________

30 Days Before Expiration:

  • Decision received: ___________
  • If denied, appeal prepared: ___________
  • Bridge therapy options explored: ___________

FAQ

How long does Florida Blue prior authorization renewal take? Standard renewals take 15-30 business days. Submit 60 days early to avoid coverage gaps.

What if Soliris moves to a non-preferred tier? Request a formulary exception with clinical documentation showing why biosimilar alternatives aren't appropriate for your specific case.

Can I get expedited renewal if my authorization expires soon? Yes, if your prescriber can demonstrate that treatment interruption poses immediate health risks. Submit expedited requests within 30 days of expiration.

Does step therapy apply to renewals if I'm already stable on Soliris? Generally no, but new Florida Blue policies may require step therapy documentation even for renewals. Check your specific plan requirements.

What happens if I switch Florida Blue plans during open enrollment? You'll need a new prior authorization for the new plan, even if you had approval with your previous Florida Blue plan.

How do I know if my prescriber is REMS-enrolled? Contact your prescriber's office directly or check with the specialty pharmacy dispensing your Soliris.

About Counterforce Health

Counterforce Health specializes in turning insurance denials into successful appeals for patients needing high-cost specialty medications like Soliris. Our platform analyzes denial letters and payer policies to create targeted, evidence-based appeals that address specific coverage criteria and maximize approval chances.

If you're facing a Soliris denial or need help with your renewal appeal, Counterforce Health can help you navigate Florida Blue's complex requirements and build a compelling case for coverage.

Sources & Further Reading

Disclaimer: This guide is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions vary by individual plan and medical circumstances. Always consult with your healthcare provider and insurance plan directly for personalized guidance. For regulatory assistance, contact the Florida Department of Financial Services Division of Consumer Services at 1-877-693-5236.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.